Innate and adaptive cellular immunity in flavivirus-naïve human recipients of a live-attenuated dengue serotype 3 vaccine produced in Vero cells (VDV3)
Authors:
- Paul K.S. ChanPCPaul K.S. Chan
- G. Neil ThomasGTG. Neil Thomas
- Bruno GuyBGBruno Guy
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Comparison by flow cytometry of immune changes induced in human monocyte-derived dendritic cells upon infection with dengue 2 live-attenuated vaccine or 16681 parental strainFEMS Immunology & Medical Microbiology, 2006
- Altered Cytokine Responses of Dengue-Specific CD4+ T Cells to Heterologous SerotypesThe Journal of Immunology, 2005
- Review on flavivirus vaccine developmentVaccine, 2005
- Dengue: an arthropod-borne disease of global importanceEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- Dengue: defining protective versus pathologic immunityJournal of Clinical Investigation, 2004
- Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai childrenThe Pediatric Infectious Disease Journal, 2004
- BIOLOGIC PROPERTIES OF DENGUE VIRUSES FOLLOWING SERIAL PASSAGE IN PRIMARY DOG KIDNEY CELLS: STUDIES AT THE UNIVERSITY OF HAWAIIThe American Journal of Tropical Medicine and Hygiene, 2003
- Dengue‐Specific T Cell Responses in Peripheral Blood Mononuclear Cells Obtained prior to Secondary Dengue Virus Infections in Thai SchoolchildrenThe Journal of Infectious Diseases, 2002
- Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio, and multiple doses.The American Journal of Tropical Medicine and Hygiene, 2002
- Induction of T lymphocyte responses to dengue virus by a candidate tetravalent live attenuated dengue virus vaccineVaccine, 2001